Review



bd3  (Multi Sciences (Lianke) Biotech Co Ltd)


Bioz Verified Symbol Multi Sciences (Lianke) Biotech Co Ltd is a verified supplier
Bioz Manufacturer Symbol Multi Sciences (Lianke) Biotech Co Ltd manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Multi Sciences (Lianke) Biotech Co Ltd bd3
    Bd3, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bd3/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 93 stars, based on 24 article reviews
    bd3 - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    93
    Multi Sciences (Lianke) Biotech Co Ltd bd3
    Bd3, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bd3/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 93 stars, based on 1 article reviews
    bd3 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Addgene inc bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Bd3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bd3/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    bd3 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    Applied Materials Inc black diamond® brand film layers bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Black Diamond® Brand Film Layers Bd3, supplied by Applied Materials Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/black diamond® brand film layers bd3/product/Applied Materials Inc
    Average 90 stars, based on 1 article reviews
    black diamond® brand film layers bd3 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Applied Materials Inc black diamond® brand film layers, e.g., bd1, bdii and bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Black Diamond® Brand Film Layers, E.G., Bd1, Bdii And Bd3, supplied by Applied Materials Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/black diamond® brand film layers, e.g., bd1, bdii and bd3/product/Applied Materials Inc
    Average 90 stars, based on 1 article reviews
    black diamond® brand film layers, e.g., bd1, bdii and bd3 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    AIEgen Biotech Co Ltd berberine dimers bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Berberine Dimers Bd3, supplied by AIEgen Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/berberine dimers bd3/product/AIEgen Biotech Co Ltd
    Average 90 stars, based on 1 article reviews
    berberine dimers bd3 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Millipore anti-bd3 antibody (cat#: d2444)
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Anti Bd3 Antibody (Cat#: D2444), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-bd3 antibody (cat#: d2444)/product/Millipore
    Average 90 stars, based on 1 article reviews
    anti-bd3 antibody (cat#: d2444) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Assay Biotechnology bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Bd3, supplied by Assay Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bd3/product/Assay Biotechnology
    Average 90 stars, based on 1 article reviews
    bd3 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    99
    Hitachi Ltd compound bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Compound Bd3, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compound bd3/product/Hitachi Ltd
    Average 99 stars, based on 1 article reviews
    compound bd3 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    93
    Addgene inc pbrm1 bd3
    (A) Coomassie gel of the purified recombinant proteins BD2, <t>BD3,</t> BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .
    Pbrm1 Bd3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbrm1 bd3/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    pbrm1 bd3 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Coomassie gel of the purified recombinant proteins BD2, BD3, BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .

    Journal: bioRxiv

    Article Title: PBRM1-Dependent PBAF Targeting is Required for EMT and Metastasis in Breast Cancer

    doi: 10.1101/2025.10.19.683137

    Figure Lengend Snippet: (A) Coomassie gel of the purified recombinant proteins BD2, BD3, BD4, BD5 and the tandem BD2-5 used for peptide and nucleosome binding assays. (B) Schematic representation of EpiCypher’s Captify™ assay. (C) Table of EC 50 values (nM) of the different BDs for the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. (D) Binding curves of tandem BD2-5 with the indicated peptides obtained using the ALPHA/dCypher assay. EC 50 (nM) values are indicated next to the corresponding curves. (E) Table of the relative EC 50 values (nM) of the different BDs for nucleosomes bearing the indicated histone modifications obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 nucleosomes is used as a positive control in this assay. (F) Binding curves of tandem BD2-5 for nucleosomes bearing the indicated peptides obtained using the ALPHA/dCypher assay. HP1 binding to H3K9me3 peptide is used as a positive control in this assay. EC 50 values (nM) obtained for positive binders are indicated in the legend. (G and H) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac at Phf10 binding sites in untreated (H) and 48h TGFβ1-treated (I) sgCt cells. (I) Correlation matrix with r-values between Phf10 and H3K14ac, H3K18ac, H3K27ac, and H3K4me3 ChIP-seq enrichment in untreated and 48h TGFβ1-treated sgCt cells. (J) Metagene plots and heatmaps of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated and 48h TGFβ1-treated sgCt cells. The top heatmap is at Phf10 binding sites in untreated cells and the bottom is Phf10 binding sites only found in TGFβ1-treated cells. (K and L) Genomic tracks of ChIP-seq enrichment of Phf10, H3K14ac, H3K18ac, and H3K27ac in untreated (M) and 48h-TGFβ1 treated (M) sgCt cells at constitutive locus Cpne2 and an inducible locus Tnfsf13b .

    Article Snippet: Constructs encoding codon-optimized ORFs for bacterial expression of human PBRM1 BD2 (addgene #39013), BD3 (addgene #39030), BD4 (addgene #39103), BD5 (addgene #38999) and tandem BD2-5 (SGC construct ID #PB1A-c080) were transformed in BL21(DE3) for BDs, and BL21 Rosetta2 (DE3) pLysS for tandem BD2-5.

    Techniques: Purification, Recombinant, Binding Assay, Positive Control, ChIP-sequencing